A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.

Item
http://www.wikidata.org/entity/Q33370292
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseThe role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literaturePhase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study GroupPrognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review.Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIDeterminants of myelosuppression in the treatment of non-small cell lung cancer with cisplatin-containing chemotherapy.Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients.Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer.Long-term chemotherapy may prolong survival in advanced non-small-cell lung cancer among responders to first-line chemotherapy.
P2860

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.

Item
http://www.wikidata.org/entity/Q33370292
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
A randomized trial in inoperab ...... with vindesine and mitomycin.
@ast
A randomized trial in inoperab ...... with vindesine and mitomycin.
@en
type
label
A randomized trial in inoperab ...... with vindesine and mitomycin.
@ast
A randomized trial in inoperab ...... with vindesine and mitomycin.
@en
prefLabel
A randomized trial in inoperab ...... with vindesine and mitomycin.
@ast
A randomized trial in inoperab ...... with vindesine and mitomycin.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
A randomized trial in inoperab ...... with vindesine and mitomycin.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698